NanoString Technologies, Inc. updated earnings guidance for the year 2023. For the year, the company expects total revenue of $175 million to $180 million, as compared to the previous range of $175 million to $185 million.
NanoString Technologies, Inc.
Equities
NSTGQ
US63009R1095
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.128 USD | -2.07% | +2.48% | -82.90% |
May. 07 | Bruker's NanoString Secures Patent Case Win in Germany | MT |
May. 07 | First Amended Reorganization Plan and Disclosure Statement Filed by NanoString Technologies, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
-82.90% | 6.29M | |
-6.88% | 180B | |
+3.18% | 112B | |
-3.57% | 68.53B | |
+5.58% | 51.97B | |
+5.47% | 44.08B | |
+5.62% | 42.23B | |
+24.30% | 32.43B | |
+16.72% | 26.39B | |
-3.70% | 24.97B |
- Stock Market
- Equities
- NSTGQ Stock
- News NanoString Technologies, Inc.
- NanoString Technologies, Inc. Updates Earnings Guidance for the Year 2023